Skip to main content

Table 4 Comparison of spontaneous stool frequency and constipation score by the use of phosphate binder

From: Efficacy and safety of elobixibat in hemodialysis patients with chronic constipation: a retrospective study

Parameter

Use of phosphate binder

Mean ± SD

p value

Baseline

Week 12 after administration

Spontaneous stool frequency

Yes

1.8 ± 0.6

4.9 ± 2.3

< 0.001

No

2.6 ± 0.9

5.2 ± 2.6

0.033

Total CSS score

Yes

10.1 ± 3.1

5.7 ± 2.7

0.002

No

11.2 ± 3.5

5.8 ± 4.8

0.058

Stool frequency

Yes

0.8 ± 0.6

0.4 ± 0.6

0.041

No

1.4 ± 0.9

0.4 ± 0.5

0.089

Dyschezia

Yes

1.8 ± 1.0

0.5 ± 0.7

0.002

No

2.2 ± 0.8

0.8 ± 1.3

0.134

A sensation of incomplete evacuation

Yes

2.2 ± 1.3

1.3 ± 1.4

0.091

No

2.0 ± 1.2

1.4 ± 1.5

0.149

Abdominal pain

Yes

1.3 ± 1.1

0.6 ± 1.2

0.101

No

0.8 ± 0.8

0.2 ± 0.4

0.149

Time to evacuation

Yes

0.9 ± 0.8

0.6 ± 0.6

0.182

No

1.0 ± 0.7

0.8 ± 1.1

0.773

Assisted bowel movements

Yes

1.1 ± 0.4

0.9 ± 0.3

0.149

No

1.2 ± 0.4

0.6 ± 0.5

0.149

Number of bowel movements failed/24 h

Yes

1.1 ± 0.5

0.3 ± 0.5

0.002

No

1.0 ± 0.0

0.2 ± 0.4

0.072

Duration (years) of suffering from disturbed defecation

Yes

0.9 ± 0.5

1.2 ± 1.0

No

1.6 ± 1.5

1.4 ± 1.7

  1. Results of analysis: patients with phosphate binder treatment n = 14, patients without phosphate binder treatment n = 5
  2. Statistical analysis was performed using the paired t-test (spontaneous stool frequency) or Wilcoxon signed-rank test (CSS scores)
  3. No statistical analysis was performed on the duration of suffering from disturbed defecation